Get answers to your arrhythmia questions by e-mailing Dr. Stephen Shorofsky.
Dr. Shorofsky's Bio | Q&A Archive
The goal of treatment is to reduce symptoms by reducing the episodes of tachycardia (rapid heart rate).
Medication may be used to control or prevent rapid heart beating. These include adenosine, antiarrhythmics, and amiodarone. Digoxin, verapamil, and beta-blockers (other drugs commonly used to treat other types of tachycardia) can increase the frequency of tachycardia episodes for some people with Wolff-Parkinson-White.
Other treatments to stop a persistent episode of tachycardia may include electrical cardioversion (shock) or catheter ablation with a special type of energy called radiofrequency. This destroys the accessory pathway using a catheter (tube) inserted into the body to reach the heart. The success rate for this procedure ragnes between 85 - 95%, depending on the location of the extra pathway.
Surgery may provide a permanent cure for Wolff-Parkinson-White. This involves ablation (destruction) of the accessory pathway using open heart surgery . Surgery may be a good approach to cure symptomatic Wolff-Parkinson-White syndrome, but it is usually only done if the patient must undergo surgery for other reasons.
The most severe form of tachyarrhythmia is atrial fibrillation. It may rapidly lead to shock, and requires emergency treatment (cardioversion).
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |